Disease-specific factors associated with cardiovascular events in patients with Takayasu arteritis.
Oh Chan KwonJung Hwan ParkYong-Beom ParkMin-Chan ParkPublished in: Arthritis research & therapy (2020)
Type V vascular involvement was associated with increased risk of cardiovascular events, while the use of methotrexate was associated with reduced risk of cardiovascular events, in patients with TAK.